EMQUIN 40MG contains Chloroquine which belongs to a group of medicines called antimalarials and amebicides. It treats malaria, amebiasis and other conditions which act by preventing the growth of parasites in the red blood cells. Chloroquine phosphate is an antimalarial and amebicidal medicine. It does not prevent relapses in patients with vivax or ovale malaria because it is not effective against exoerythrocytic forms of the parasites.
Before receiving EMQUIN 40MG inform your doctor if you have liver, kidney or heart problems, are pregnant or breastfeeding. Your doctor will administer the right dose depends on your child’s age and body weight. The common side effects are vomiting, weakness, stomach pain, diarrhea, loss of appetite and nausea.
Chloroquine acts by killing the organisms which causes malaria and amebiasis. It works by preventing the growth of parasites in the red blood cells.
EMQUIN 40MG will be administered by your physician or nurse. Your doctor will administer the right dose depending on your condition.
Diarrhoea:
Drink plenty of fluids and ORS can be used to prevent dehydration.
Stomach pain:
Place a warm water bottle on your abdomen. Soak in a warm bath and drink plenty of clear fluids and water.
Headache:
Rest and drink plenty of fluids. Ask your doctor to recommend a painkiller.
Nausea:
Take normal regular meals and do not eat spicy foods.
Vomiting:
Drink clear or ice-cold drinks. Eat light, bland foods and avoid fried, greasy, sweet foods.
EMQUIN 40MG should be used with caution during pregnancy. Consult your doctor for advice.
EMQUIN 40MG should be used with caution during breastfeeding. Consult your doctor for advice.
Consumption of alcohol is not recommended during treatment with EMQUIN 40MG.
EMQUIN 40MG should be used with caution in patients with active kidney diseases. Consult your doctor for advice.
EMQUIN 40MG should be used with caution in patients with active liver diseases. Consult your doctor for advice.
Tell your doctor if you are allergic (hypersensitive) to Chloroquine.
EMQUIN 40MG should be used with caution in patients suffering from active heart diseases. Consult your doctor for advice.
Tell your doctor if you have or had,
Tell your doctor if you are taking, or have recently taken any other medicines, including medicines obtained without a prescription or vitamins and herbal supplements.
Drug | : | Chloroquine |
Pharmacological Category | : | Antimalarials and Amebicides |
Therapeutic Indication | : | Treats Malaria and Extraintestinal amebiasis |
Dosage Forms | : | Tablet, Injection, Oral suspension |
Store below 20-25°C and keep out of reach of children.
Can EMQUIN 40MG be used during breastfeeding?
It should be used with caution during breastfeeding. Consult your doctor for advice.
Does EMQUIN 40MG cause nausea?
It may cause nausea in some individuals, if this persists for a long time then consult your doctor for advice.
Is EMQUIN 40MG safe?
Yes, it is safe if prescribed by your physician. However, tell your doctor if you have any liver, kidney or heart diseases.
1. KD Tripathi MD. Antimicrobial drugs. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page – 786.
2. Vinetz JM, Clain J, Bounkeua V, et al. Chemotherapy of Malaria. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page: 1402-1405.
3. Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page - 630.
4. PJ. Antiprotozoal Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page - 901-904.
5. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 248-249.
6. Rosa Elena Mejia Torres, Engels Ilich Banegas, Meisy Mendoza, Cesar Diaz, Sandra Tamara Mancero Bucheli, Gustavo A. Fontecha, Md Tauqeer Alam, Ira Goldman, Venkatachalam Udhayakumar, and Jose Orlinder Nicolas Zambrano. Efficacy of Chloroquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Honduras. May 01, 2013; [Accessed on June 10, 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752747/
7. L. A. Salako, A. F. Aderounmu, and O. Walker. Influence of route of administration on the pharmacokinetics of chloroquine and desethylchloroquine. 1987. [Accessed on June 10, 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490847/
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.